The NPAA 14th Annual Conference will be held VIRTUALLY on November 14th from
8 AM - 3 PM. Enjoy the conference in the comfort of your own home!
This conference will provide the opioid guideline update required for the DEA and QACSC renewals, informative speakers, and the NPAA business meeting which will focusing on FPA legislation. The conference will be hosted as a Zoom Webinar. The cost of this conference is $50. A combination conference registration plus NPAA membership is offered for $100.
8:00-8:15: Welcome - D'Ann Somerall, NPAA President
8:15-9:45: Opioid Guideline Update Part 1 - Beverly Jordan, M.D.
9:50-11:25 Opioid Guideline Update Part 2 - John Meigs, M.D.
11:30-12:15: Protocols and Pitfalls of Prescribing with Pathways to Problem Preventions - Suzanne Lazenby, RN
12:15-12:30: Question and Answers
12:30-1:00: NPAA Business Meeting- What's Happening with FPA Legislation - D'Ann Somerall, NPAA President
1:00-2:00: Assessment and Management of Patients with Diabetes Type 2 and Lower Urinary Tract Symptoms (LUTS) (.5 Pharm & .5 General CE) - Lisa Pair, DNP and Bella Patel, DNP
2:00-3:00: Stop the Stroke: The Updated 2019 Guidelines for Thromboembolic Prevention in Patients with Atrial Fibrillation (1 CE Pharm) - Jennifer Miller, DNP